Arranta Bio
Arranta Bio LLC is a contract development and manufacturing organization based in Watertown, Massachusetts, with a facility in Gainesville, Florida. Founded in 2019, the company specializes in the development and manufacturing of live biopharmaceutical products, particularly live biotherapeutic products (LBPs) aimed at addressing diseases related to the human microbiome. Arranta Bio offers a range of services, including media formulation, cell banking, fermentation, lyophilization, and drug product finishing, all compliant with cGMP standards. Additionally, the company provides analytical services to support its clients in the healthcare sector. By focusing on bacterial fermentation and encapsulation techniques, Arranta Bio enables innovators to develop effective therapies for clinical and commercial use.
Thymmune Therapeutics is a biotechnology company developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease.
Captozyme Inc. is a biotechnology company based in Gainesville, Florida, focused on developing therapeutic enzymes that degrade oxalate, a substance linked to kidney stones and certain orphan disorders. Established in 2016, the company aims to help patients manage their diets and health by eliminating non-nutrient oxalate from their bodies. One of its key products, Nephure, allows individuals to enjoy various foods without the adverse effects of oxalate accumulation. Through innovative research and scientific expertise, Captozyme seeks to advance healthcare standards by utilizing novel enzymes and live biotherapeutics. As of November 2019, Captozyme operates as a subsidiary of Arranta Bio LLC.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.